Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions

Clinical Immunology

Volumn 131, Issue 3, 2009, Pages 415-425

  Pachiadakis, Ioannis ^a   Chokshi, Shilpa ^a   Cooksley, Helen ^a   Farmakiotis, Dimitrios ^b   Sarrazin, Christoph ^c   Zeuzem, Stefan ^c   Michalak, Tomasz I ^d   Naoumov, Nikolai V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Infectious Diseases Hospital of Thessaloniki   (Greece)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Antiviral treatment; Dendritic cells; Hepatitis C

Indexed keywords

CORE PROTEIN; INTERLEUKIN 12; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADAPTIVE IMMUNITY; ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; MALE; PERSISTENT VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS GENOME; VIRUS LOAD;

ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERLEUKIN-12; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; VIREMIA;

EID: 67349169169     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.02.001     Document Type: Article

References (46)

1. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., and Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191 (2000) 1499-1512
2. Poynard T., Yuen M.F., Ratziu V., and Lai C.L. Viral hepatitis C. Lancet 362 (2003) 2095-2100
3. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30 (2000) 2479-2487
4. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., and Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194 (2001) 1395-1406
5. Thimme R., Bukh J., Spangenberg H.C., Wieland S., Pemberton J., Steiger C., Govindarajan S., Purcell R.H., and Chisari F.V. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15661-15668
6. Cramp M.E., Carucci P., Rossol S., Chokshi S., Maertens G., Williams R., and Naoumov N.V. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44 (1999) 424-429
7. Botarelli P., Brunetto M.R., Minutello M.A., Calvo P., Unutmaz D., Weiner A.J., Choo Q.L., Shuster J.R., Kuo G., Bonino F., et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104 (1993) 580-587
8. Steinman R.M., and Witmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U. S. A 75 (1978) 5132-5136
9. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
10. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
11. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., and Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163 (1999) 6762-6768
12. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., and Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186 (1997) 813-823
13. + T cells. J. Exp. Med. 186 (1997) 801-812
14. Moutaftsi M., Mehl A.M., Borysiewicz L.K., and Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99 (2002) 2913-2921
15. Pollara G., Speidel K., Samady L., Rajpopat M., McGrath Y., Ledermann J., Coffin R.S., Katz D.R., and Chain B. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187 (2003) 165-178
16. Raftery M.J., Schwab M., Eibert S.M., Samstag Y., Walczak H., and Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15 (2001) 997-1009
17. Servet-Delprat C., Vidalain P.O., Bausinger H., Manie S., Le Deist F., Azocar O., Hanau D., Fischer A., and Rabourdin-Combe C. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol. 164 (2000) 1753-1760
18. Auffermann-Gretzinger S., Keeffe E.B., and Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97 (2001) 3171-3176
19. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., and Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120 (2001) 512-524
20. Dolganiuc A., Kodys K., Kopasz A., Marshall C., Do T., Romics Jr. L., Mandrekar P., Zapp M., and Szabo G. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170 (2003) 5615-5624
21. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., Sasaki Y., Kasahara A., and Hori M. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162 (1999) 5584-5591
22. Rollier C., Drexhage J.A., Verstrepen B.E., Verschoor E.J., Bontrop R.E., Koopman G., and Heeney J.L. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38 (2003) 851-858
23. Sarobe P., Lasarte J.J., Zabaleta A., Arribillaga L., Arina A., Melero I., Borras-Cuesta F., and Prieto J. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J. Virol. 77 (2003) 10862-10871
24. Sarobe P., Lasarte J.J., Casares N., Lopez-Diaz d.C., Baixeras E., Labarga P., Garcia N., Borras-Cuesta F., and Prieto J. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76 (2002) 5062-5070
25. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., and Rice C.M. Patients chronically infected with hepatitis C virus have functional dendritic cells. Blood (2003)
26. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., and Rice C.M. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103 (2004) 1026-1029
27. Piccioli D., Tavarini S., Nuti S., Colombatto P., Brunetto M., Bonino F., Ciccorossi P., Zorat F., Pozzato G., Comar C., Abrignani S., and Wack A. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J. Hepatol. 42 (2005) 61-67
28. Barnes E., Salio M., Cerundolo V., Francesco L., Pardoll D., Klenerman P., and Cox A. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus. J. Viral Hepatitis 15 (2008) 219-228
29. Zimmermann M., Flechsig C., La Monica N., Tripodi M., Adler G., and Dikopoulos N. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J. Hepatol. 48 (2008) 51-60
30. Longman R.S., Talal A.H., Jacobson I.M., Rice C.M., and Albert M.L. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J. Infect. Dis. 192 (2005) 497-503
31. Dolganiuc A., Chang S., Kodys K., Mandrekar P., Bakis G., Cormier M., and Szabo G. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 177 (2006) 6758-6768
32. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., Oki C., Itose I., Hiramatsu N., Takehara T., Kasahara A., and Hayashi N. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190 (2004) 1919-1926
33. Mellor J., Hawkins A., and Simmonds P. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J. Clin. Microbiol. 37 (1999) 2525-2532
34. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., MacSween R.N., et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22 (1995) 696-699
35. Rehermann B., and Naoumov N.V. Immunological techniques in viral hepatitis. J. Hepatol. 46 (2007) 508-520
36. Tang K.H., Herrmann E., Cooksley H., Tatman N., Chokshi S., Williams R., Zeuzem S., and Naoumov N.V. Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. J. Hepatol. 43 (2005) 776-782
37. Pham T.N., MacParland S.A., Mulrooney P.M., Cooksley H., Naoumov N.V., and Michalak T.I. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78 (2004) 5867-5874
38. Lanford R.E., Chavez D., Chisari F.V., and Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69 (1995) 8079-8083
39. Laperche S., Le Marrec N., Simon N., Bouchardeau F., Defer C., Maniez-Montreuil M., Levayer T., Zappitelli J.P., and Lefrere J.J. A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 43 (2003) 958-962
40. Tobler L.H., Stramer S.L., Lee S.R., Baggett D., Wright D., Hirschkorn D., Walsh I., and Busch M.P. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Vox Sang. 89 (2005) 201-207
41. Tillmann H.L., Wiegand J., Glomb I., Jelineck A., Picchio G., Wedemeyer H., and Manns M.P. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay. Z. Gastroenterol. 43 (2005) 11-16
42. Li W., Li J., Tyrrell D.L., and Agrawal B. Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities. J. Gen. Virol. 87 (2006) 61-72
43. Li W., Krishnadas D.K., Li J., Tyrrell D.L., and Agrawal B. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy. J. Immunol. 176 (2006) 6065-6075
44. Goutagny N., Fatmi A., Ledinghen V.D., Penin F., Couzigou P., Inchauspe G., and Bain C. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J. Infect. Dis. 187 (2003) 1951-1958
45. Ludwig I.S., Lekkerkerker A.N., Depla E., Bosman F., Musters R.J., Depraetere S., van Kooyk Y., and Geijtenbeek T.B. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J. Virol. 78 (2004) 8322-8332
46. Barnes E., Salio M., Cerundolo V., Medlin J., Murphy S., Dusheiko G., and Klenerman P. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob. Agents Chemother. 48 (2004) 3382-3389